首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Multigene amplification and massively parallel sequencing for cancer mutation discovery
【24h】

Multigene amplification and massively parallel sequencing for cancer mutation discovery

机译:用于癌症突变发现的多基因扩增和大规模并行测序

获取原文
获取原文并翻译 | 示例
       

摘要

We have developed a procedure for massively parallel resequencing of multiple human genes by combining a highly multiplexed and target-specific amplification process with a high-throughput parallel sequencing technology. The amplification process is based on oligonucleotide constructs, called selectors, that guide the circularization of specific DNA target regions. Subsequently, the circularized target sequences are amplified in multiplex and analyzed by using a highly parallel sequencing-by-synthesis technology. As a proof-of-concept study, we demonstrate parallel resequencing of 10 cancer genes covering 177 exons with average sequence coverage per sample of 93%. Seven cancer cell lines and one normal genomic DNA sample were studied with multiple mutations and polymorphisms identified among the 10 genes. Mutations and polymorphisms in the TP53 gene were confirmed by traditional sequencing.
机译:我们已经开发了一种程序,通过将高度复用的和靶标特异性扩增过程与高通量并行测序技术相结合,对多个人类基因进行大规模并行重测序。扩增过程基于称为选择子的寡核苷酸构建体,该构建体指导特定DNA靶区域的环化。随后,通过高度并行的合成测序技术,对环化的靶序列进行多重扩增和分析。作为概念验证研究,我们证明了10个癌症基因的平行重测序,这些基因覆盖177个外显子,每个样品的平均序列覆盖率为93%。研究了7个癌细胞系和1个正常基因组DNA样品,在10个基因中发现了多个突变和多态性。 TP53基因的突变和多态性已通过传统测序得到证实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号